Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Spooner

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Trends in Biotechnology|July 1, 1990
Immunotoxins: status and prospectsR A Spooner, J M Lord
Perspectives in Public Health|April 12, 2025
Dopamine-scrolling: a modern public health challenge requiring urgent attentionB T Sharpe, R A Spooner
Journal of Bacteriology|August 1, 1987
Activation of the xylDLEGF promoter of the TOL toluene-xylene degradation pathway by overproduction of the xylS regulatory gene productR A Spooner, M Bagdasarian, F C Franklin
Journal of General Microbiology|May 1, 1986
Genetic, functional and sequence analysis of the xylR and xylS regulatory genes of the TOL plasmid pWW0R A Spooner, K Lindsay, F C Franklin
Gene Therapy|June 1, 1995
Genetic delivery of enzymes for cancer therapyM P Deonarain, R A Spooner, A A Epenetos
Gene Therapy|May 1, 1995
DNA vaccination for cancer treatmentR A Spooner, M P Deonarain, A A Epenetos
Immunology Today|December 1, 1994
Applications of monoclonal antibodies in clinical oncologyA J George, R A Spooner, A A Epenetos
Advances in Biotechnological Processes|January 1, 1989
Immunotoxins: monoclonal antibody-toxin conjugates--a new approach to cancer therapyJ M Lord, R A Spooner, L M Roberts
British Journal of Cancer|February 1, 1993
A recombinant single chain antibody interleukin-2 fusion proteinP Savage, A So, R A Spooner, et al.
Cell Biophysics|January 1, 1993
A recombinant single-chain antibody interleukin-2 fusion proteinP Savage, A So, R A Spooner, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Trends in Biotechnology|July 1, 1990
Immunotoxins: status and prospectsR A Spooner, J M Lord
Perspectives in Public Health|April 12, 2025
Dopamine-scrolling: a modern public health challenge requiring urgent attentionB T Sharpe, R A Spooner
Journal of Bacteriology|August 1, 1987
Activation of the xylDLEGF promoter of the TOL toluene-xylene degradation pathway by overproduction of the xylS regulatory gene productR A Spooner, M Bagdasarian, F C Franklin
Journal of General Microbiology|May 1, 1986
Genetic, functional and sequence analysis of the xylR and xylS regulatory genes of the TOL plasmid pWW0R A Spooner, K Lindsay, F C Franklin
Gene Therapy|June 1, 1995
Genetic delivery of enzymes for cancer therapyM P Deonarain, R A Spooner, A A Epenetos
Gene Therapy|May 1, 1995
DNA vaccination for cancer treatmentR A Spooner, M P Deonarain, A A Epenetos
Immunology Today|December 1, 1994
Applications of monoclonal antibodies in clinical oncologyA J George, R A Spooner, A A Epenetos
Advances in Biotechnological Processes|January 1, 1989
Immunotoxins: monoclonal antibody-toxin conjugates--a new approach to cancer therapyJ M Lord, R A Spooner, L M Roberts
British Journal of Cancer|February 1, 1993
A recombinant single chain antibody interleukin-2 fusion proteinP Savage, A So, R A Spooner, et al.
Cell Biophysics|January 1, 1993
A recombinant single-chain antibody interleukin-2 fusion proteinP Savage, A So, R A Spooner, et al.
Pageof 3